Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.46 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.46 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.46 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.43 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.43 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.43 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thioglycolic Acid SCHEMBL21017 | 1.00 | — | — | |
| Thioglycolic Acid SCHEMBL16760983 | 0.95 | — | — | |
| Thioglycolic Acid SCHEMBL1275214 | 0.95 | — | — | |
| Thioglycolic Acid SCHEMBL9357348 | 0.95 | — | — | |
| Thioglycolic Acid SCHEMBL10424203 | 0.95 | — | — | |
| Thioglycolic Acid SCHEMBL10796026 | 0.95 | — | — | |
| Thioglycolic Acid SCHEMBL7033331 | 0.95 | — | — | |
| Thioglycolic Acid SCHEMBL10815859 | 0.95 | — | — | |
| Thioglycolic Acid SCHEMBL3273734 | 0.95 | — | — | |
| Thioglycolic Acid SCHEMBL60835 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119530153-A | Use of non-inflammatory microvesicles that induce macrophage secretion by beta-glucan in the treatment of inflammation | 中国人民解放军军事科学院军事医学研究院 | 2025-02-28 | — | — | CN | disclosed |
| CN-114423500-B | Composition for dyeing keratin fibres and use thereof | 莱雅公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-114080212-B | Capsule for cosmetics | 株式会社LG生活健康 | 2024-12-27 | — | — | CN | disclosed |
| CN-118103023-A | Retarder composition and dye set comprising same | 莱雅公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-117999288-A | Humanized anti-C5 a antibodies and uses thereof | 宾夕法尼亚大学理事会 | 2024-05-07 | — | — | CN | disclosed |
| CN-117731696-A | Application of bacteroides ovatus for protecting cerebral neurons | 中南大学湘雅医院 | 2024-03-22 | — | — | CN | disclosed |
| CN-111868084-B | Therapies and methods for treating TLR 2-mediated diseases and conditions | 加利福尼亚大学董事会 | 2024-03-22 | — | — | CN | disclosed |
| CN-117651546-A | Oxidation retardant composition | 莱雅公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-117615746-A | Dye set | 莱雅公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-117597104-A | Combination for dyeing keratin fibres and use thereof | 莱雅公司 | 2024-02-23 | — | — | CN | disclosed |
| US-20090100610-A1 | Mixture of Sulfide Dyes | CIBA CORPORATION | 2009-04-23 | — | — | US | disclosed |
| CN-101326246-A | Mixture of sulfide dyes | CIBA SC HOLDING AG (CH) | 2008-12-17 | — | — | CN | disclosed |
| CN-101243139-A | Styryl sulfide dyes | CIBA SC HOLDING AG (CH) | 2008-08-13 | — | — | CN | disclosed |
| EP-1937780-A2 | MIXTURE OF SULFIDE DYES | Ciba Holding Inc. (CH) | 2008-07-02 | — | — | EP | disclosed |
| EP-1893695-A2 | STYRYL SULFIDE DYES | Ciba Specialty Chemicals Holding Inc. (CH) | 2008-03-05 | — | — | EP | disclosed |
| CN-1889925-A | Use of polymers based on n-vinyl caprolactam in hair cosmetics | BASF AG (DE) | 2007-01-03 | — | — | CN | disclosed |
| WO-2006136617-A2 | MIXTURE OF SULFIDE DYES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006134043-A2 | STYRYL SULFIDE DYES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-12-21 | — | — | WO | disclosed |
| CN-1684658-A | Use of polymers based on N-vinyl caprolactam | BASF AG (DE) | 2005-10-19 | — | — | CN | disclosed |
| US-6316623-B1 | USEFUL FOR SCREENING IN BIOLOGICAL ASSAYS IN ORDER TO IDENTIFY PHARMACEUTICALLY USEFUL COMPOUNDS | ISIS PHARMACEUTICALS, INC. | 2001-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090100610-A1 | Mixture of Sulfide Dyes | KRT18, TST, ARSA | LMNA 2959/4885LDHA 737/4885SRR 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.